PRTA (Prothena Corporation plc) Stock Market Reviews

crown

search

Read and share opinions on PRTA (Prothena Corporation plc) stock. Join MyTopStock.com to discover reviews, insights, and discussions from investors about this company's performance in the stock market

PRTA

Prothena Corporation plc

clarify Biotechnology

bookmark Healthcare

public Ireland

Sell Neutral Buy

Latest News

Prothena (PRTA) Reports Q3 Loss, Lags Revenue Estimates
Nov 6, 2025
Prothena: Q3 Earnings Snapshot
Nov 6, 2025
Prothena Corporation plc (PRTA): A Bull Case Theory
Oct 22, 2025
One Prothena Insider Raised Their Stake In The Previous Year
Oct 16, 2025
Prothena’s Partner Bristol Myers Squibb Obtains Fast Track Designation from the U.S. FDA for BMS-986446 (PRX005), an Anti-MTBR-Tau-Targeting Antibody, for the Treatment of Alzheimer’s Disease
Oct 1, 2025
Prothena (PRTA) Up 17.6% Since Last Earnings Report: Can It Continue?
Sep 3, 2025
Prothena to Participate in the Cantor Fitzgerald Global Healthcare Conference
Aug 28, 2025
Prothena (PRTA) Reports Q2 Loss, Lags Revenue Estimates
Aug 4, 2025
Prothena: Q2 Earnings Snapshot
Aug 4, 2025

Reviews